Sekar Kathiresan

Sekar Kathiresan was the founder of Verve Therapeutics, Inc., founded in 2018, where the title held was Chief Executive Officer & Director.
Dr. Kathiresan was the founder of Maze Therapeutics, Inc., founded in 2017, with the title of Independent Director from 2022 to 2025.
The current job is Independent Director at Relay Therapeutics, Inc. starting in 2022.
Former jobs include Director at Center for Genomic Medicine Massachusetts General Hospital from 2016 to 2019, Director-Cardiovascular Disease Initiative at The Broad Institute, Inc. from 2014 to 2019, Assistant Physician at The General Hospital Corp.
from 1997 to 2021, and Professor at Harvard Medical School from 2018 to 2021.
Education includes undergraduate degree from the University of Pennsylvania and doctorate from Harvard Medical School.